TBI(TBI)
TBI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.75B | $1.81B |
| Low | $1.72B | $1.78B |
| High | $1.78B | $1.84B |
| EBITDA Avg | $32M | $33M |
| Low | $31M | $32M |
| High | $32M | $34M |
| EBIT Avg | $3M | $3M |
| Low | $3M | $3M |
| High | $3M | $4M |
| Net Income Avg | $-497,493 | $24M |
| Low | $-508,230 | $24M |
| High | $-486,756 | $25M |
| EPS Avg | $-0.02 | $0.82 |
| Low | $-0.02 | $0.80 |
| High | $-0.02 | $0.83 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $468M | $437M | $423M | $452M | $472M | $458M |
| Low | $464M | $428M | $419M | $448M | $468M | $454M |
| High | $472M | $447M | $426M | $457M | $477M | $462M |
| EBITDA Avg | $9M | $8M | $8M | $8M | $9M | $8M |
| Low | $8M | $8M | $8M | $8M | $9M | $8M |
| High | $9M | $8M | $8M | $8M | $9M | $8M |
| EBIT Avg | $903,632 | $844,225 | $815,745 | $873,340 | $912,108 | $883,733 |
| Low | $895,264 | $826,222 | $808,190 | $865,252 | $903,661 | $875,548 |
| High | $912,001 | $862,228 | $823,299 | $881,428 | $920,554 | $891,917 |
| Net Income Avg | $6M | $4M | $-1M | $7M | $11M | $9M |
| Low | $6M | $2M | $-1M | $7M | $11M | $8M |
| High | $6M | $6M | $-1M | $7M | $11M | $9M |
| EPS Avg | $0.19 | $0.14 | $-0.04 | $0.24 | $0.36 | $0.28 |
| Low | $0.18 | $0.05 | $-0.04 | $0.24 | $0.36 | $0.28 |
| High | $0.19 | $0.20 | $-0.04 | $0.24 | $0.36 | $0.28 |
| Analysts (Rev / EPS) | 1 / 2 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |